Cabot Undervalued Stocks Advisor Special Bulletin
A Spanish news outlet, Intereconomia.com, is reporting that biotech company Amgen (AMGN) is in talks to buy Alexion Pharmaceuticals (ALXN) for close to $200 per share.
Read More
retail sales
Read More
retail sales Archives
Current Market Update
From Cabot Top Ten Trader
Despite all the moves of the past couple of weeks and today’s headlines, nothing has really changed with our overall view. Looking at the primary evidence, the market’s intermediate-term trend has yet to turn positive—all major indexes continue to around...
Read More
Cabot Global Stocks Explorer 692
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Dividend Investor Weekly Update
The market seems to be rebounding and stabilizing after a tumultuous couple of weeks. The escalation of trade tensions, a sputtering global economy and talk of the next recession spooked investors. But as fear wanes investors realize that money has no place else go...
Read More
Cabot Stock of the Week 261
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
Today’s and next week’s issues of Cabot Undervalued Stocks Advisor are going to look a bit different. I won’t be reviewing all of our portfolio stocks today. Many Wall Street analysts are on vacation, so there will be very little in the way changes...
Read More
Cabot Prime Pro Week Ending August 23, 2019
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Prime Week Ending August 23, 2019
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Marijuana Investor Update
Yesterday’s strong market triggered a technical indicator, a follow-through signal that tells us buyers are lurking. Of course, today’s big decline so far isn’t good to see, but nevertheless, this and other measures (awful sentiment, etc.) tell us there should be support on weakness.
Read More
Cabot Growth Investor 1426
Play Some Defense
Usually, when the market is doing well, stocks aren’t affected much by the news of the day. That’s not to say individual stocks don’t get pushed around, but for the market as a whole, worrisome headline news usually goes the way water...
Read More
Cabot Dividend Investor Weekly Update
This week is a still familiar story in the portfolio, with defensive stocks thriving and moving still higher.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
U.S. stock markets have exhibited a high degree of volatility in recent weeks. There are lots of factors contributing to the turmoil, which will ebb and flow, probably for the rest of our lives. So let’s just circle back to why we’re here: here...
Read More
Cabot Stock of the Week 260
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Marijuana Investor Update
The good news is that many cannabis companies have been releasing their second quarter reports and the results have been excellent.
Read More
Cabot Prime Pro Week Ending August 16, 2019
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Prime Week Ending August 16, 2019
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
Four stocks in our portfolios reported earnings this week.
Read More
Cabot Global Stocks Explorer 691
Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More
Cabot Dividend Investor Weekly Update
The market has undergone a radical personality transformation since I released the July issue last week. I’m not hitting the panic button, yet. But it is certainly a situation I will closely monitor.
Read More
Wall Street’s Best Investments 820
Market Views
No Longer Overbought
Technically, the S&P 500 has corrected most of an overbought condition with a 2.73% decline from its July 16 high. News-related volatility will likely continue as the market enters its least favorable season. But, sentiment gauges have begun to improve a..
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up